Search Results - "Vose JM"

Intensified chemotherapy for diffuse large B-cell lymphomas.

Authors: Vose JM (AUTHOR)

Source: Lancet. 11/26/2011, Vol. 378 Issue 9806, p1828-1829. 2p.

Human immunodeficiency virus-associated plasmablastic lymphoma: Poor prognosis in the era of highly active antiretroviral therapy.

Authors: Castillo JJ Furman M Beltrán BE et al.

Source: Cancer (0008543X). Nov2012, Vol. 118 Issue 21, p5270-5277. 8p.

Efficacy and safety of epcoritamab in relapsed or refractory large B-cell lymphoma: 3-year update from the EPCORE NHL-1 trial.

Authors: Karimi YH Cheah CY Clausen MR et al.

Source: Annals of hematology [Ann Hematol] 2026 Feb 04; Vol. 105 (3), pp. 79. Date of Electronic Publication: 2026 Feb 04.

Publication Type: Journal Article; Multicenter Study

Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE

Functional genomics and tumor microenvironment analysis reveal prognostic biological subtypes in Mantle cell lymphoma.

Authors: Sharma S Ali R Bouska A et al.

Corporate Authors: Sharma S Ali R Bouska A et al.

Source: Nature communications [Nat Commun] 2025 Nov 05; Vol. 16 (1), pp. 9762. Date of Electronic Publication: 2025 Nov 05.

Publication Type: Journal Article

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Benchmarking the Current Landscape: Insights From an Association of American Cancer Institutes Survey on Academic Cancer Service Lines.

Authors: Fracasso PM Simone NL Si Lim SJ et al.

Source: JCO oncology practice [JCO Oncol Pract] 2026 Jul; Vol. 22 (7), pp. 1278-1285. Date of Electronic Publication: 2025 Sep 24.

Publication Type: Journal Article

Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101758685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2688-1535 (Electronic) Linking ISSN: 26881527 NLM ISO Abbreviation: JCO Oncol Pract Subsets: MEDLINE

Persistence of PET scan positivity after chemoimmunotherapy for DLBCL.

Authors: Armitage JO Lunning MA Vose JM et al.

Source: Blood advances [Blood Adv] 2026 May 12; Vol. 10 (9), pp. 3061-3066.

Publication Type: Journal Article; Review

Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

Proteome landscape of B-cell malignancies identifies mantle cell lymphoma protein signature.

Authors: Swenson SA Winship CB Dobish KK et al.

Source: BioRxiv : the preprint server for biology [bioRxiv] 2026 Apr 27. Date of Electronic Publication: 2026 Apr 27.

Publication Type: Journal Article; Preprint

Journal Info: Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE

Pirtobrutinib, a highly selective, noncovalent (reversible) BTKi in R/R marginal zone lymphoma: phase 1/2 BRUIN study.

Authors: Patel K Vose JM Nasta SD et al.

Source: Blood advances [Blood Adv] 2026 Apr 14; Vol. 10 (7), pp. 2441-2451.

Publication Type: Journal Article; Clinical Trial, Phase II; Clinical Trial, Phase I

Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

Hematological Oncology journal women in lymphoma special issue: Latest updates in nodal peripheral T-cell lymphoma.

Authors: Poon L de Leval L Ng SB et al.

Source: Hematological oncology [Hematol Oncol] 2024 Nov; Vol. 42 (6), pp. e3191. Date of Electronic Publication: 2023 Jun 13.

Publication Type: Journal Article; Review

Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8307268 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1099-1069 (Electronic) Linking ISSN: 02780232 NLM ISO Abbreviation: Hematol Oncol Subsets: MEDLINE

Pirtobrutinib, a highly selective, noncovalent (reversible) BTKi in R/R follicular lymphoma: phase 1/2 BRUIN study.

Authors: Shah NN Zinzani PL Wang M et al.

Source: Blood advances [Blood Adv] 2025 Dec 09; Vol. 9 (23), pp. 5954-5964.

Publication Type: Journal Article; Clinical Trial, Phase II; Clinical Trial, Phase I; Multicenter Study

Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

Cooperative role of distinctive TP53 and PTEN combined loss in the peripheral T cell lymphoma-GATA3 molecular subgroup.

Authors: Lone WG Yu J Liu X et al.

Corporate Authors: Lone WG Yu J Liu X et al.

Source: Science advances [Sci Adv] 2025 Oct 17; Vol. 11 (42), pp. eadx6877. Date of Electronic Publication: 2025 Oct 17.

Publication Type: Journal Article

Journal Info: Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101653440 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2375-2548 (Electronic) Linking ISSN: 23752548 NLM ISO Abbreviation: Sci Adv Subsets: MEDLINE

NCCN Guidelines® Insights: B-Cell Lymphomas 3.2025.

Authors: Zelenetz AD Gordon LI Abramson JS et al.

Source: Journal of the National Comprehensive Cancer Network : JNCCN [J Natl Compr Canc Netw] 2025 Oct; Vol. 23 (10).

Publication Type: Journal Article; Practice Guideline

Journal Info: Publisher: Harborside Press Country of Publication: United States NLM ID: 101162515 Publication Model: Print Cited Medium: Internet ISSN: 1540-1413 (Electronic) Linking ISSN: 15401405 NLM ISO Abbreviation: J Natl Compr Canc Netw Subsets: MEDLINE

Integrative Genomic and Transcriptomic Analysis Reveals Targetable Vulnerabilities in Angioimmunoblastic T-Cell Lymphoma.

Authors: Bouska A Zhang W Sharma S et al.

Source: American journal of hematology [Am J Hematol] 2025 Sep; Vol. 100 (9), pp. 1486-1501. Date of Electronic Publication: 2025 Jun 13.

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE

Integrative analysis of clinicopathological features defines novel prognostic models for mantle cell lymphoma in the immunochemotherapy era: a report from The North American Mantle Cell Lymphoma Consortium.

Authors: Vose JM Fu K Wang L et al.

Corporate Authors: Vose JM Fu K Wang L et al.

Source: Journal of hematology & oncology [J Hematol Oncol] 2023 Dec 16; Vol. 16 (1), pp. 122. Date of Electronic Publication: 2023 Dec 16.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Biomed Central Country of Publication: England NLM ID: 101468937 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-8722 (Electronic) Linking ISSN: 17568722 NLM ISO Abbreviation: J Hematol Oncol Subsets: MEDLINE

Current Treatments in Mantle Cell Lymphoma.

Authors: Avyakta Kallam Md Vose JM

Source: Oncology (Williston Park, N.Y.) [Oncology (Williston Park)] 2023 Aug 08; Vol. 37 (8), pp. 326-333.

Publication Type: Journal Article

Journal Info: Publisher: MultiMedia Healthcare Country of Publication: United States NLM ID: 8712059 Publication Model: Print Cited Medium: Internet ISSN: 0890-9091 (Print) Linking ISSN: 08909091 NLM ISO Abbreviation: Oncology (Williston Park) Subsets: MEDLINE

Final results of a phase II study of CHOEP plus lenalidomide as initial therapy for patients with stage II-IV peripheral T-cell lymphoma.

Authors: Stuver R Horwitz SM Advani RH et al.

Source: British journal of haematology [Br J Haematol] 2023 Aug; Vol. 202 (3), pp. 525-529. Date of Electronic Publication: 2023 May 22.

Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE

Lenalidomide maintenance following high-dose therapy and autologous haematopoietic stem cell transplantation in chemo-resistant or high-risk non-Hodgkin lymphoma: A phase I/II study.

Authors: Vose JM Ganguly S Bierman PJ et al.

Source: British journal of haematology [Br J Haematol] 2023 Jul; Vol. 202 (1), pp. 116-121. Date of Electronic Publication: 2023 Apr 25.

Publication Type: Clinical Trial, Phase II; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE

Severity of Cytokine Release Syndrome Influences Outcome After Axicabtagene Ciloleucel for Large B cell Lymphoma: Results from the US Lymphoma CAR-T Consortium.

Authors: Jacobs MT Jain MD Gao F et al.

Source: Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2022 Oct; Vol. 22 (10), pp. 753-759. Date of Electronic Publication: 2022 May 23.

Publication Type: Journal Article; Research Support, N.I.H., Extramural

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101525386 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2152-2669 (Electronic) Linking ISSN: 21522669 NLM ISO Abbreviation: Clin Lymphoma Myeloma Leuk Subsets: MEDLINE

Characteristics and Outcome of Extranodal NK/T-Cell Lymphoma in North America: A Retrospective Multi-Institutional Experience.

Authors: Bennani NN Tun AM Carson KR et al.

Source: Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2022 Apr; Vol. 22 (4), pp. e250-e260. Date of Electronic Publication: 2021 Oct 16.

Publication Type: Journal Article; Multicenter Study

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101525386 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2152-2669 (Electronic) Linking ISSN: 21522669 NLM ISO Abbreviation: Clin Lymphoma Myeloma Leuk Subsets: MEDLINE

Phase 1 trial of carfilzomib in relapsed/refractory peripheral T-cell lymphoma.

Authors: Krishnan M Bociek RG Fanale M et al.

Source: Annals of hematology [Ann Hematol] 2022 Feb; Vol. 101 (2), pp. 335-340. Date of Electronic Publication: 2021 Oct 20.

Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study

Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE